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Abstract: The aim of our project was to study the effect of streptozotocin (STZ)—induced hyperglycemia on sciatic nerve morphology,
blood plasma markers and immunohistochemical expression of RAGE (the Receptor for Advanced Glycation End-products), and its
ligands—S100B and Carboxymethyl Lysine (CML)-advanced glycation endproduct (AGE) in the laboratory pig. Six months after
STZ—injections, blood plasma measurements, morphometric analysis of sciatic nerve fiber density, immunofluorescent distribution of
potential molecular neuropathy contributors, ELISA measurement of plasma AGE level and HPLC analysis of sciatic nerve levels of
one of the pre-AGE and the glycolysis intermediate products—methyl-glyoxal (MG) were performed. The results of our study revealed
that STZ—injected animals displayed elevated levels of plasma glucose, gamma glutamyl transferase (GGT) and triglycerides. The
sciatic nerve of STZ-injected pigs revealed significantly lower numbers of small-diameter myelinated fibers, higher immunoreactivity
for RAGE and S100B and increased levels of MG as compared to control animals. Our results correspond to clinical findings in human
patients with hyperglycemia/diabetes-evoked peripheral neuropathy and suggest that the domestic pig may be a suitable large animal
model for the study of mechanisms underlying hyperglycemia-induced neurological complications in the peripheral nerve and may
serve as a relevant model for the pre-clinical assessment of candidate drugs in neuropathy.
Keywords: pig, sciatic nerve, RAGE, AGE, S100B, CML
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Introduction

Metabolic and morphological changes in peripheral
nerves are the most common nervous system
complications in patients with diabetes, often leading to
the development of a diabetic polyneuropathy (DPN),
predominately affecting sensory and autonomic
function of peripheral nerves.1–3 The molecular
mechanisms underlying the pathogenesis of these
diabetes related changes are not yet fully understood,
but lack of neurotrophic support,4 oxidative stress,
activation of Protein Kinase C (PKC) pathway and
enhanced protein glycation leading to accumulation
of Advanced Glycation End-products (AGEs)5–7 are
among the major causes of neuronal dysfunction.
AGEs, among which carboxymethyllysine (CML)—
AGE group is most common, are heterogeneous
class of molecules modifying cellular function by an
array of distinct mechanisms, including ligation and
activation of the signal transduction receptor, RAGE
(Receptor for Advanced End-Glycation products).7
Extensive studies on RAGE and its function in hyperglycemia/diabetes conducted in STZ-induced type 1
diabetes small animal models have shown that RAGE
is upregulated in diabetic tissues such as heart, retina
and peripheral nerve, affecting the function of these
organs and subsequently leading to the development
of atherosclerosis and peripheral neuro-, retinoand nephropathy.8,9 Furthermore, it has been shown
that the activation of RAGE by one of its ligands,
S100B, a calcium binding protein and glial/Schwann
cell marker, in dorsal root ganglion (DRG) cultures
increases cellular oxidative stress, resulting in sensory
neuron injury, neuronal apoptosis and nerve dysfunction, factors likely contributing to the development
of peripheral neuropathy.10 Additionally, it has been
noted that the expression of S100B is elevated in
neurodegenerative disorders and acute brain injuries,
making this protein a potential biomarker and possible
modulator of nervous system injury.11,12 In our study,
we have focused on establishing the morphological
and molecular evidence of peripheral nervous system
diabetic complications in the pig, taking advantage of
its close physiological resemblance with the human
organism.13
Particularly in the field of diabetes, the pig
has gained considerable interest, as its metabolic,
biochemical and pathophysiological responses to the
disease mimic in part those observed in humans.14,15
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It has been shown that blood supply of the porcine
pancreas is similar to that of human pancreas and
the number of beta-cells is within similar range as
observed in humans making in a valuable model for
the study of diabetes. The most stable and commonly
accepted pig model of diabetes is STZ-induced type 1
diabetes (diabetes mellitus),14,15 where glucose metabolism and insulin secretion remain at the very similar
level as in human diabetic patients. To date, the type 1
STZ-induced hyperglycemic/diabetic pig model has
been predominately validated in studies of the cardiovascular complications of the disease16–18 while neuronal complications in this model are unclear. Thus,
the aim of this paper is to extend the body of research
in this, latter, area as well as provide novel data on
distribution of RAGE and its binding partners in
peripheral nervous system in the hyperglycemic pig.

Materials and Methods
Animals

Twelve juvenile castrated male Yorkshire pigs,
weighing from 17.1 kg to 23.2 kg, (ABI, Inc.
Danboro, PA, USA) were used in this study. The pigs
were divided into two groups—six diabetic and six
control—and were individually housed in enriched
environment cages. Prior to the experiment initiation,
the pigs were given one week of acclimatization to
observe their general health, to minimize physiological
stress and to ensure proper conduct of the study.
After acclimatization, hyperglycemia was induced
as previously described.19 Briefly, animals were
anesthetized and injected intravenously with 50 mg/kg
sterile streptozotocin (STZ) solution in citrate buffer
(100 mM, pH 4.5; Sigma, St. Louis, MO, USA)
for three consecutive days while control pigs were
injected with equal amounts of vehicle (citrate buffer).
During induction of hyperglycemia, experimental
pigs were fed normal chow supplemented with dextrose (2× per day, 25 g, Sigma, St. Louis, MO, USA)
to offset the anticipated insulin release. Afterwards
they were fed a 10% high fat, 1.5% high cholesterol
diet (Harlan Tekland, Madison, WI, USA) to mimic
diabetic hyperlipidemia. The control pigs remained on
a normal chow diet throughout the whole time of the
experiment. One of the six experimental pigs required
treatment with insulin glargine (0.2 mg/kg, SanofiAventis, Bridgewater, NJ, USA) subcutaneously once
daily to prevent recurrent diabetic ketoacidosis for
Biochemistry Insights 2010:3
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the last 12 weeks of the experiment. At administered
doses of insulin, blood glucose levels were maintained
at hyperglycemic values above 20 mmol/l until
sacrifice. Due to the space limits, control animals
were sacrificed four weeks before diabetic animals.
The experimental pigs were sacrificed 6 months after
induction of hyperglycemia. All animal procedures
were performed in accordance with the Principles of
Laboratory Animal Care (NIH publication no. 85-23,
rev. 1985) and were approved by the Columbia
University Institutional Animal Care and Use
Committee.

Physiological status and general health
condition evaluation

Plasma glucose levels were measured prior to the
experiment initiation, 7 days after the first STZ
injection and then once per month for the duration
of the experiment using a hand-held glucometer.
Glucose levels were monitored monthly until the end
of the experiment or when indicated by a change in
the clinical status of the pig. To assess physiological
status and to evaluate the general condition of
animals, weight measurement and routine blood tests
for hemoglobin, blood urea nitrogen (BUN), gamma
glutamyl transferase (GGT), creatinine, cholesterol
and triglyceride were performed on the initial day of
the experiment, and at 4, 8, 12 and 24 weeks after
hyperglycemia induction.

Methyl-glyoxal (MG) measurement

Extracts of sciatic nerve (50–70 mg) from control
and hyperglycemic animals were collected on the
final day of the experiment, digested with perchloric
acid (0.5 M) and the neutralized supernatant was
derivatized to 2-methylquinoxaline (MQ, 1:1) as
previously described.20 Levels of MG were then
indirectly measured by determining the levels of MQ
by HPLC at 335 nm.

AGE measurement

Establishment of AGE baseline level was conducted
on the day of experiment initiation and blood AGE
levels were measured 3 and 6 months after the
hyperglycemia induction. Briefly, samples were
prepared according to standard protocol,21 transferred
onto 96 well plates, blocked for 1 h at room temperature
in blocking buffer (5% GSA, 1% BSA in 0.1 M PBS,
Biochemistry Insights 2010:3

pH 7.4) and incubated for 3 h at room temperature
with an affinity-purified chicken antibody against
AGEs diluted 1:100 in blocking buffer.22 After primary
antibody incubation, samples were washed several
times with PBS and subsequently incubated with goat
anti-chicken IgG at 1:10,000 dilution in blocking
buffer, developed and read by spectrophotometer at
490 nm. Results were given in arbitrary AGE units
(AAU), as previously described.21

Morphological analysis of peripheral
nerve changes

Animals were euthanized by intravenous pentobarbital injections (Euthasol, 120 mg/kg, Henry Schein,
Melville, NY, USA). A longitudinal skin incision
at the upper hindlimb level with blunt separation
of gluteal muscles was performed to expose the
sciatic nerve and 10 mm long nerve fragments were
collected. After collection, samples were immediately transferred to fixative (2.5% glutaraldehyde
and 2% paraformaldehyde (PFA) in 0.1 M PBS,
pH 7.4) and stored at 4 °C until further processing.
For morphological analysis, samples were postfixed
in 1% osmium tetroxide (0.1 M Phosphate Buffer),
dehydrated with serial washing in ethanol (50%,
75%, 95% -2 × 10 min and 100% -3 × 10 min),
infiltrated with propylene oxide (1–2 hr) and embedded in low viscosity epoxy medium (Spurr, Electron
Microscopy Sciences, Hatfield, PA, USA). Cross
sections were cut at 0.5 µm thickness using a 2088
ultratome (LKB Produkter AB, Bromma, Sweden),
stained with toluidine blue and examined with
an Axioscope 2 Plus microscope (Zeiss, Thornwood, NY, USA). Images were captured using the
Axiovision computer analysis system (Zeiss, Thornwood, NY, USA) connected to CCD Axiocam video
camera. The myelinated fiber density quantification
was performed using ImageJ 7.1 (NIH open source
software, USA) with Cell Counter plug-in. One cross
section of sciatic nerve fascicule from five control
and five diabetic animals was analyzed. Within one
cross section, three fascicles, largest, medium and
the smallest, fitting into 400 × 400 µm square, were
selected for quantification to ensure proper counting
methodology.23–25 Discrimination between small
(3.3–3.7 µm Ø) and large (11.2–21.6 µm Ø) fibers
was set manually and standardized in all studied
samples.
49
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Immunofluorescence (IF)

Sciatic nerve samples from diabetic and control animals
(euthanasia procedure as previously described) were
collected, transferred to fixative (4% PFA in destilled
H2O) for 12 h, cryoprotected in 20% sucrose solution
for 24 h, mounted in optimal cutting temperature
compound (Tissue-Tek O.C.T., Sakura Finetek,
Zoeterwoude, Netherlands) and stored at −20 °C for
further processing. Alternatively, collected samples
were immediately snap-frozen in liquid nitrogen
and stored in −80 °C without prior fixation. Frozen
samples were cut transversely and longitudinally
at 10 µm thickness on a cryostat (Microm HM 550,
Thermo Scientific, Waltham, MA, USA) and collected
on polylysine coated slides (SuperFrost Plus, Fisher
Scientific, Pittsburgh, PA, USA), always in the same
order—1st series with two diabetic and two control
sections from 4 different animals in total and 2nd series
with 4 sections (control or diabetic) from 1 animal, to
ensure similar staining condition and to minimize risk
of false positive or false negative results. After slide
collection, PFA-fixed sections were allowed to dry for
30 min at room temperature, while non-fixed sections
were first transferred into containers with cold acetone,
fixed for 5 min and then similar to PFA sections, and
then they were allowed to dry for 30 min. Afterwards,
all tissue sections were processed according to standard immunostaining protocol. In brief, dried sections
were incubated with blocking solution (Cas-block,
Invitrogen, Carlsbad, CA, USA) for 1 h, incubated in
primary antibodies for 16 hours (for details, see antibody section), rinsed 4 × 5 min in PBS, incubated with
secondary antibodies for 1 h, rinsed again for 4 × 5 min
in PBS and mounted in fluorescent mounting medium
(DAKO, Carpinteria, CA, USA). Mounted sections
were allowed to stabilize for 30 min and afterwards
were examined at 200x and 400x using a Scanning
Confocal System (Bio-Rad Radiance 2000, Zeiss,
Thornwood, NY, USA) attached to Nikon Eclipse 800
with krypton-argon and red diode lasers (excitation
lines 488, 568, and 637 nm). Double immunostained
images were acquired in a sequential mode to avoid
bleed-through effect. All image acquisition parameters
were kept identical for each studied specimen. To
optimize the specificity of the labeling, the concentration of each primary antibody was tested in trial series
ranging from 1:50 to 1:500 and the optimal dilution
was used for experimental staining. To establish the
50

s pecificity of the secondary antibodies, standard
immunostaining procedure with omission or replacement of primary antibodies on sections from each
sample was carried out parallel to the experimental
staining. Quantification of immunofluorescent signal
from control and hyperglycemic tissues single stained
for RAGE and its ligands CML and S100B was calculated using ImageJ histogram function for RGB
images and obtained as mean grey value of pixels per
selected region of interest26 given in arbitrary units
(IAU). Colocalization percentage of RAGE positive
fibers double stained for ligands and markers was calculated manually using ImageJ Cell Counter Plugin,
where number of RAGE positive fibers was used as a
reference number (100% of all positive fibers).
The following primary antibodies were used:
polyclonal rabbit anti-RAGE and polyclonal
anti-S100B generated as described earlier (Ma et al
2007), polyclonal goat anti-RAGE, 1:200 (GeneTex,
Irvine, CA, USA); polyclonal rabbit anti-Vesicular
Acetylocholine Transporter (VAChT), 1:500, rabbit
anti-Tyrosine Hydroxylase (TH), 1:200, rabbit
anti-Calcitonin Gene Related Peptide (CGRP), 1:200,
monoclonal mouse anti-Macrophage Marker (MM,
25F9)—86 kD cell surface and cytoplasmic protein
of mature human macrophages, 1:100 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA); polyclonal
rabbit anti-Neurofilament (NF), 1:400 and polyclonal
affinity purified anti-Munc13-1, 1:400 (Synaptic
Systems, Goettingen, Germany. The following
secondary antibodies were used: chicken anti-goat
Alexa 568, 1:300, chicken anti-rabbit Alexa 488,
1:200 and Alexa 568, 1:300 and rabbit anti-mouse
Alexa 488, 1:200 (Invitrogen, Carlsbad, CA, USA).

Statistics

Statistical analysis was performed using SPPS 13
(SPPS Inc., Chicago, IL, USA) or GraphPad, InStat
(GraphPad Software, Inc., La Jolla, CA, USA). All
values are presented as mean ± SEM. The statistical
significance of differences was evaluated by ANOVA
or Student’s t-test as defined in the text.

Results
Plasma glucose level

The baseline plasma glucose level in animals measured before STZ treatment and the development of
hyperglycemia was within standard reference values for
Biochemistry Insights 2010:3
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the pig (2.91 ± 0.16 mmol/l). The significant 5.4 -fold
(15.62 ± 0.87 mmol/l) increase in glucose level was
already observed on the 7th day after STZ injection,
followed by 7.8 fold increase (22.76 ± 1.27 mmol/l)
1 month after the injection. Monthly measurements performed until the final day of sacrifice revealed sustained,
high levels of plasma glucose in the range of 22.6–
25.42 mmol/l (Table 1). ANOVA and post-hoc TukeyKramer analysis revealed statistical significance between
baseline and all further data point values (P , 0.001).

Physiological status and routine
laboratory diagnostic marker evaluation

Routine health examination did not show any
abnormalities throughout the entire period of the experiment. The initial weight of the experimental pigs was
19.73 ± 0.87 kg, increasing over the course of the
experiment to a peak weight at 4 months of diabetes
(27.6 ± 4.8 kg). Body weight subsequently declined to
20.4 ± 3.08 kg by the end of the experiment. Levels of
Hb and BUN remained within normal reference values
at all given time points, however there was a statistically
significant progressive decline of Hb values over the
duration of experiment (ANOVA, post-hoc TukeyKramer test, P , 0.005). Creatinine levels were slightly
below reference values, but no statistical difference was
noted between baseline and given data points. Additionally, there was a trend toward an increase in the
levels of GGT and Triglyceride over the course of the
experiment. Furthermore, significant increases in LDL

and Cholesterol, between baseline and 3-month values
were noted (ANOVA, post-hoc Tukey-Kramer test,
P , 0.005) and for HDL between baseline and all studied
time points. Diagnostic marker values for control animals
remained within standard reference range throughout the
entire duration of the experiment (Table 1).

Tissue Methyl-glyoxal and Plasma AGE
measurement

HPLC analysis of sciatic nerve tissue revealed a low
level of MG in control sciatic nerve tissue, ranging
from 0.171 to 0.226 µm/g while in hyperglycemic
sciatic nerve MG levels were ~22 fold higher (range,
2.98−5.33 µm/g reaching statistical significance
(ANOVA, post-hoc Tukey-Kramer test, P , 0.05)
(Fig. 1A). As MGs are pre-AGE species, we examined levels of circulating AGEs in the plasma of diabetic animals and observed a trend toward a gradual
increase in plasma AGE levels in the diabetic pigs.
The baseline plasma AGE level was established prior
to the experiment, estimated as 57.55 ± 5.82 AAU.
At 3 months after STZ injection, plasma AGE
level reached 75.33 ± 24.34 AAU, and at 6 months
118.45 ± 50.35 AAU (~2 fold increase) (Fig. 1B).

Morphological analysis
of peripheral nerves

Noticeable loss of small diameter myelinated fibers
and some morphological changes were observed in
sciatic nerve structure of diabetic animals (Fig. 2B, A

Table 1. Hematological and biochemical parameters were measured to assess physiological status of diabetic animals.
Similarly to human diabetic patients, pigs with hyperglycemia also exhibit hyperlipidemia. Detailed statistical analysis in
Material and Method section.
Substance

Initial
(pre-STZ)

1 month

2 months

3 months

Reference
values*

Glucose (mmol/l)
Hemoglobin (mmol/l)
BUN (mmol/l)
Creatinine (µmol/l)
GGT (U/l)
Cholesterol (mmol/l)
Triglyceride (mmol/l)
LDL (mmol/l)
HDLD (mmol/l)

2.91 ± 0.16
6.79 ± 0.25
2.59 ± 0.42
53.04 ± 9.72
47.33 ± 6.5
2.73 ± 0.14
0.65 ± 0.14
1.56 ± 0.22
0.87 ± 0.11

22.76 ± 1.27
5.70 ± 0.19
5.96 ± 0.69
54.80 ± 3.27
61.16 ± 1.9
6.35 ± 1.31
1.19 ± 0.48
3.72 ± 1.12
2.29 ± 0.13

22.6 ± 1.27
5.74 ± 0.09
6.74 ± 6.74
67.18 ± 9.72
71.5 ± 13.56
6.95 ± 1.54
2.33 ± 0.88
4.47 ± 1.156
2.37 ± 0.14

24.01 ± 1.34
5.85 ± 0.13
6.19 ± 1.26
74.26 ± 13.23
69.5 ± 10.72
8.96 ± 1.54
2.85 ± 1.17
5.03 ± 1.11
2.51 ± 0.03

1.50–3.5
5.5–10.4
0.70–7.85
106–180
14–34
1.3–2.6
0.2–0.65
0.6–2
0.6–2

*Swindel M. Appendix. Hematology and Serum Chemistry. In: Swindel M, Swine in the laboratory: Surgery, Anaesthesia, Imaging and Experimental
Techniques. 2nd ED, CRC Press; 2007:409 Bollen PJ. Hansen AK, Rasmusen HJ. Important Biological Features. Normative Values. In: The laboratory
swine. CRC Press, 2000: 14. Winnicka A. Reference Values of common laboratory tests in veterinary medicine (In Polish). Warszawa, Poland. Wydawnictwo
SGGW. 1997 Holevet et al. Arterioscler Thromb Vasc Biol. 1998;18:415–22 (and references within).
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µm/g

CML (Fig. 6A, B) and S100B (Fig. 6C, D) revealed
variable colocalization patterns depending on the
protein studied, demonstrating significantly higher
number of RAGE positive fibers co-stained for NF
(91% ± 5%, Fig. 4C), and lower number co-stained
for TH (58% ± 2%, Fig. 5H), CGRP (42% ± 4%,
Fig. 5I) and S100B (82% ± 12%, Fig. 6H) compared
to the control animals. (paired T-test, P , 0.05).
Macrophage Marker (MM) staining revealed a lack
of macrophage positive signal in the control group,
but distinct well defined perineurium staining in the
diabetic group (Fig. 6E, F).

Methyl-glyoxal level

5

*

4
3
2
1
0

AAU
180
160
140
120
100
80
60
40
20
0

Hyperglycemic

Plasma AGE level

Discussion

Arbitrary AGE units

B

Control

baseline

Pre-STZ

3 months

6 months

Figure 1. A) Methyl-glyoxal levels in sciatic nerve tissue. Sciatic nerve tissue was retrieved and subjected to HPLC analysis for detection of levels
of pre-AGE methyl-glyoxal (MG). As shown, hyperglycemic animals had
significantly higher level of MG compared to the controls, *P , 0.05.
B) Plasma AGE levels. AGE levels were measured by ELISA in the
plasma and compared with the baseline level to determine the degree of
glycation occurring during sustained hyperglycemia.

respectively). The overall density of myelinated fibers of
diabetic pigs was lower compared to the control group
(Fig. 2D, C respectively). The nerve morphology was
evaluated based on the size of fiber diameter. The number of large diameter myelinated nerve fibers was similar
between both groups (control, 898.54 ± 70.57 per mm
vs. hyperglycemic, 1,001.04 ± 113.49 per mm). However, the number of small diameter myelinated fibers
was significantly lower (~19%) in hyperglycemic samples (control 332.29 ± 19.83 vs. diabetic 260.62 ± 22.42
per mm; Paired T-test, P , 0.05) (Fig. 2E).

Immunofluorescence

Assessment of single staining immunofluorescence
signal revealed changes in immunohistochemical
expression for RAGE (Fig. 3A, B) and one of
its ligands, S100B (Fig. 3E, F), whereas CML
(Fig. 3C, D) remained consistent between control
and hyperglycemic nerve samples. Furthermore,
quantification of double-stained fibers positive both for
RAGE and marker proteins NF (Fig. 4A, B), VAChT
(Fig. 5A, B), TH (Fig. 5C, D), CGRP (Fig. 5E, F),
52

Our study demonstrates that the porcine sciatic nerve
after 6 months of sustained hyperglycemia exhibits
alterations in fiber density often observed in human
patients with long-term diabetes. In addition, the
results of our study provide for the first time the preliminary evidence of the expression of RAGE and its
ligands in the porcine peripheral nerves and provide
insight into MG, AGE precursor, and AGE levels in
nerve and circulating blood, respectively, of healthy
and STZ-injected pigs. Expression of the studied proteins as well as the level of neural MG is noticeably
higher in hyperglycemic tissues and an increased
trend in plasma AGE level is observed during the
course of disease. Furthermore, the results of the
routine laboratory plasma lipid tests were consistent
with the data obtained from human subjects, suggesting, as shown recently in hyperglycemic patients
with diagnosed peripheral neuropathy, that elevated
levels of plasma lipids correlate with progression of
neurological changes and neuropathy under diabetic/
hyperglycemic conditions.27,28 The alteration of fiber
density and morphology and significant loss of the
small diameter fibers in the peripheral sciatic nerve
are characteristic morphological signs of progressive
neuropathy in human diabetic patients,29,30 Until now,
the data on early structural changes in the peripheral
nerve of hyperglycemic/diabetic animals was by far
limited to the studies on small animal models and
therefore almost by definition redundant as compared
to studies on larger, closer genetically, anatomically
and physiologically related species, often failing to
replicate subtle, sub-clinical metabolic, biochemical
and/or morphological changes.31,32 As shown in
studies on neuropathy in type 1 diabetic mouse,
Biochemistry Insights 2010:3
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B

Control

C

Hyperglycemic

1200

Number of fibers per mm

E

D

Control
Hyperglycemic

1000
800
600

*

400
200
0

Large fibers

Small fibers

Figure 2. A, B) Sciatic nerve morphometry. Semi-thin toluidine blue sections prepared from control pig sciatic nerve reveal a dense network of large
diameter myelinated fibers motor and small diameter myelinated sensory regularly-shaped fibers, whereas sections from a hyperglycemic sciatic nerve
reveal visible loss of small fibers; overall fiber morphology is altered suggesting the onset of sensorimotor neuropathy. C, D) Lower panel images magnify
nerve morphology, displaying large and small fibers in the control sections and indicating increase in the number of irregular shaped fibers (asterisks) in
the diabetic nerve. E) Quantification of fiber number was performed on the indicated sections and reported as values per mm. *P , 0.05.

structural deficits and symptomatic manifestation of
the developing neurological abnormalities are less
prominent and often delayed, as compared to human
subjects at the relative stage of the disease, thus fail
to serve as a probe of early DBN manifestation.33
Strikingly, in the same pig model investigations on
retinal morphological aberrations revealed that,
in correlation with our data, 6 months of sustained
Biochemistry Insights 2010:3

h yperglycemia results in basement membrane
thickening further supporting the notion that the STZinduced pig model might be a useful tool aimed at
capturing early signs of metabolic and morphological
disturbances evoked by chronically elevated level of
glucose. It has been well established that sustained
elevations of blood glucose levels affect and alter
the physiology of many organs, leading indirectly
53

Juranek et al
CONTROL

B

HYPERGLYCEMIC

IAU

RAGE

CML
F

*

12
10

Control

8

Hyperglycemic

6
4
2
0

D

IAU

12

Mean pixel grey value

C

RAGE

14

Mean pixel grey value

A

CML
Control
Hyperglycemic

10
8
6
4
2
0

G

IAU

S100B

S100B

Mean pixel grey value

12
10

*

Control
Hyperglycemic

8
6
4
2
0

Figure 3. Assessment of immunofluorescent signal in sciatic nerve sections single stained for RAGE and its ligands. Difference in immunofluorescent
signal between control and hyperglycemic tissues was observed for RAGE (A, B) and S100B (E, F) indicating that under hyperglycemic conditions immunoexpression of these two proteins is increased. Level of CML (C, D) immunofluorescent signal was relatively low in both groups of animals and did not
reach significant difference, however visible increase of CML positive fibers was noticed in hyperglycemic nerves suggesting that hyperglycemia likely
induces immunoexpression changes of AGEs in the peripheral nerve over long period of time. *P , 0.05.

to the peripheral nervous system malfunctions.
Hyperglycemia-induced oxidative stress and the subsequent increase in free radical production leads to
cellular dysfunction and neuronal cell loss both via
activation of apoptosis or necrotic cell death. As
reported in human studies, sensory and/or autonomic
fibers are usually affected early in diabetic patients.30
Very late evidence of sensory fiber dysfunction may be
detected by standard neurological examination combined with physiological tests, but early onset of sensory dysfunction might be easily overlooked and/or
masked by other symptoms of diabetes until patients
develop severe, painful neuropathy, as pointed out in
an earlier report.34 Our morphological studies revealed
a significant ~19% loss of small diameter fibers in the
sciatic nerve at 6 months of hyperglycemia, which is
the first detection of such loss reported to date in the
peripheral nervous system in a large animal model.
Similarly, a loss of cardiac nerve fibers was observed
54

e lectrophysiologically in hyperglycemic pigs.18 Our
study supports the notion that observable loss of nerve
fibers might be also influenced by the dietary regimen
and hyperlipidemia, as reported in studies on obese
human subjects35 and observed in alimentary diabetes
models in rodents.36,37
In addition to the morphological findings, our
immunohistochemical studies demonstrate differential
expression of RAGE and its two ligands in peripheral
nerve tissue, previously not reported in this species and
tissue. As observed in single and double staining images,
RAGE immunofluorescence was more prominent in the
hyperglycemic samples, present not only in the nerve
itself but also in the surrounding vessels. Its expression
in relation to neuronal marker, Neurofilament expressed
by all fibers, revealed that in the control/healthy nerve
tissue RAGE presence is confined rather to supportive
cells than nerve fibers however as the co-staining with
type- specific fiber markers revealed, the RAGE signal
Biochemistry Insights 2010:3
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C

Colocalization

%
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*

Control
Hyperglycemic
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0

Figure 4. Neuronal RAGE staining. Confocal images of double immunostaining of RAGE (red) with the neuronal marker, Neurofilament (NF, green).
Colocalization of RAGE and NF is very low in the control tissue (A), but it is observed in the diabetic tissue (B), suggesting that RAGE presence might
be largely limited to Schwann cells in sciatic nerves of healthy animals but it is localized to nerve fibers in the hyperglycemic animals. As expected under
hyperglycemic conditions, an increase in RAGE staining is not only observed in the nerve but also in surrounding blood vessels (B). The quantitative
analysis of the colocalization pattern revealed significant difference in number of RAGE positive fibers co-stained for NF between control and hyperglycemic animals (C). *P , 0.03.

might be also detected in few motor, sensory or autonomic fibers. Hyperglycemic tissue staining revealed
an increased presence of RAGE in all types of fibers
and blood vessels which is consistent with previous
reports on RAGE in murine diabetic tissues. RAGE,
commonly linked and often cited as a molecule mediating and aggravating complications occurring in
hyperglycemic states and inflammation disorders,9 disBiochemistry Insights 2010:3

played increased expression levels based on immunohistochemical staining evaluation in the hyperglycemic
vs. control nerve samples. It is well known that in several pathological states such as diabetes, atherosclerosis
and neurodegenerative diseases, RAGE expression is
elevated in response to the increased level of newly
forming AGEs and other ligands.9 Until now, increased
expression of RAGE in the porcine peripheral nerve
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Figure 5. Immunofluorescence analysis of RAGE distribution in different types of sciatic nerve fibers. Control and diabetic sciatic nerve tissues were subjected to RAGE (red) co-immunostaining with VAChT (motor neuron marker, A, B, green), TH (autonomic neuron marker, C, D, green) and CGRP (sensory
neuron marker, E, F, green). Overlay images show that RAGE is localized in all types of sciatic nerve fibers. Note that the perineurial immunofluorescence
was non-specific as observed in control staining with the secondary antibody alone. The quantitative analysis of the colocalization pattern revealed that
although the number of double stained RAGE/VAChT positive fibers was similar in both groups of animals, there was a significantly lower number of
RAGE/TH and RAGE/CGRP positive fibers between control and diabetic animals (G, H, I), supporting our earlier morphological findings on autonomic and
sensory fiber loss in diabetic nerve. *P , 0.001.

has not been shown. Taking into account available data
obtained from our previous rodent studies and our current findings, a possible RAGE—ligand interaction
metabolic pathway in diabetic neuropathy might be
suggested. Briefly, RAGE-ligand interaction through
intermediate signal transduction processes such as
NF-KB and MAP kinase pathways38,39 may lead to
increased cellular oxidative stress and thus contribute
56

to nerve cell damage and dysfunction. Furthermore,
it has been shown that genetic deletion of RAGE in
mice correlates with lower expression of NF-KB in sensory dorsal root ganglia (DRG) neurons, as well as in
sensory sural nerve fibers.34,40
Interestingly, RAGE co-localization with its two
ligands, CML and S100B, revealed that in control
tissue there is a high degree of RAGE/ligand
Biochemistry Insights 2010:3
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Figure 6. Colocalization of RAGE and its ligands S100B and CML and RAGE co-expression with macrophage marker (MM). Sciatic nerve sections from
control and diabetic animals were subjected to RAGE (red) co-immunostaining with CML (Carboxymethyl Lysine, A, B, green), S100B (ligand/Schwann
cell marker, C, D, green), MM (macrophage marker, E, F, green). The quantitative analysis of the colocalization pattern revealed that there was a
significant difference in number of RAGE/S100B positive fibers between control and hyperglycemic animals (G, H). *P , 0.001.

c o-localization indicating that under physiological
conditions, RAGE and its ligands are expressed at
baseline levels in a limited numbers of nerve fibers
and most likely interact with each other, producing
RAGE-ligand complexes. In hyperglycemic tissue,
there is a relevant increase in both CML and
S100B expression, however the absolute value of
co-localization of these two proteins with RAGE
decreases, suggesting that both RAGE and its ligands
may interact with other proteins as well. CML, one
Biochemistry Insights 2010:3

of the advanced glycation products and a biomarker
of oxidative stress, accumulates at the higher rate
in diabetes contributing along with other AGEs
to the development of diabetes complications.41
Furthermore, a recent report on CML showed that
its accumulation is increased in aqueous humor of
retina in diabetic patients and this increase correlates
with the progression of retinopathy in those patients42
suggesting, as observed in our study, that similar correlation might take place in pathogenesis of DPN.
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S100B has been demonstrated to exert, in nanomolar
concentrations, a positive effect on axonal outgrowth,
neuronal differentiation and survival during development and injury of peripheral nerves. However,
higher micromolar concentrations of this protein and
its binding to RAGE leads to neurotoxicity resulting
in neuronal cell apoptosis, production of free radicals
and caspase cascade activation in cultured cells.43
S100B, apart from interacting with RAGE, has multiple binding domains through which it is able to
interfere with cytoskeletal molecules and hence it
may play an important role in events occurring at
the axonal endings in normal and pathological conditions such as acute/chronic injury or neurodegenerative disorders.44 Furthemore, increased observed
macrophage positive cells around the hyperglycemic neural tissue confirmed an inflammatory status
of hyperglycemic peripheral nerve suggesting the
influence of RAGE on neuropathy from multiple
sources.
In conclusion, our study addresses for the first
time the state of the peripheral nerve in thehyperglycemic STZ-induced diabetic pig. Our results indicate
that after 6 months of hyperglycemia, morphological
aberrations of peripheral nerve fibers and noticeable
loss of the small diameter fibers occur in the pig and
suggest that STZ-injected pigs might serve as a relevant model in early studies of peripheral nerve changes
under hyperglycemic conditions. Furthermore, our
data reveals that levels of pre-AGE, AGEs and RAGE
are modulated in the peripheral nerve of the STZinjected pig in early-stage hyperglycemia. This finding provides background for more detailed studies on
RAGE-ligand contribution to pathogenesis of peripheral nerve changes as well as reference data for further, pre-clinical studies on hyperglycemia-related
neuronal changes in the species more closely related
to humans.
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